• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于一种新的手术分期系统的新冠相关鼻眶脑毛霉菌病全手术清创结果:一项队列研究

Outcome of Total Surgical Debridement of Covid Associated Rhino-Orbito-Cerebral Mucormycosis Based on a New Surgical Staging System: A Cohort Study.

作者信息

Kurup Lekshmy R, Singh Harshita, Sharma Shilpee Bhatia, Janakiram Trichy Narayanan

机构信息

Royal Pearl Hospital, Trichy, Tamil Nadu India.

出版信息

Indian J Otolaryngol Head Neck Surg. 2024 Feb;76(1):298-308. doi: 10.1007/s12070-023-04151-z. Epub 2023 Aug 29.

DOI:10.1007/s12070-023-04151-z
PMID:38440527
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10908694/
Abstract

To propose a surgical staging system with management protocol for post-covid Rhino-orbito-cerebral mucormycosis (ROCM) with central skull base osteomyelitis. A prospective cohort study of a total of 193 post-covid ROCM patients was conducted between May 2021 and January 2022 at a tertiary care centre. Patients were assessed radiologically and staged from I to V. Follow up period was 16 months and the surgical outcome in terms of recurrent disease was assessed. A total of 193 patients (129 primary and 64 revision) were studied. Maxilla was found to be the epicenter of anterior disease (69.3%) and pterygoid wedge was noted to be the epicenter of posterior disease (85.6%). More than 65% of our patients, at the time of presentation, presented with involvement of the central skull base. Intracranial disease was noted in 13.9% of patients and the mortality rate was 6.2%. This staging system provides a systematic step-by-step protocol for the management of ROCM, with emphasis on meticulous disease clearance at the central skull base.

摘要

提出一种针对伴有中央颅底骨髓炎的新冠后鼻眶脑型毛霉菌病(ROCM)的手术分期系统及管理方案。2021年5月至2022年1月期间,在一家三级医疗中心对总共193例新冠后ROCM患者进行了一项前瞻性队列研究。对患者进行放射学评估并从I期到V期进行分期。随访期为16个月,并评估了复发性疾病方面的手术结果。共研究了193例患者(129例初次手术和64例翻修手术)。发现上颌骨是前部疾病的中心部位(69.3%),翼状楔被认为是后部疾病的中心部位(85.6%)。超过65%的患者在就诊时出现中央颅底受累。13.9%的患者出现颅内疾病,死亡率为6.2%。该分期系统为ROCM的管理提供了一个系统的逐步方案,强调在中央颅底进行细致的病灶清除。

相似文献

1
Outcome of Total Surgical Debridement of Covid Associated Rhino-Orbito-Cerebral Mucormycosis Based on a New Surgical Staging System: A Cohort Study.基于一种新的手术分期系统的新冠相关鼻眶脑毛霉菌病全手术清创结果:一项队列研究
Indian J Otolaryngol Head Neck Surg. 2024 Feb;76(1):298-308. doi: 10.1007/s12070-023-04151-z. Epub 2023 Aug 29.
2
Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.COVID-19 时代的 ROCM(鼻眶脑毛霉菌病)流行的手术和医学管理及其结果- 一家三级护理中心的经验。
J Mycol Med. 2022 May;32(2):101238. doi: 10.1016/j.mycmed.2021.101238. Epub 2021 Dec 25.
3
Skull Base Involvement in Covid Associated Rhino-Orbital-Cerebral Mucormycosis: A Comprehensive Analysis.新冠相关鼻眶脑毛霉菌病中的颅底受累:综合分析
Indian J Otolaryngol Head Neck Surg. 2023 Apr 8;75(3):1-13. doi: 10.1007/s12070-023-03717-1.
4
COVID-19-associated rhino-orbito-cerebral mucormycosis: a single center prospective study of 264 patients.新型冠状病毒肺炎相关鼻眶脑型毛霉菌病:一项对264例患者的单中心前瞻性研究
Orbit. 2025 Feb;44(1):24-33. doi: 10.1080/01676830.2024.2377249. Epub 2024 Jul 25.
5
Various Treatment Modalities in COVID-19 Associated Facial Mucormycosis and the Need for its Surgical Management: A Systematic Review.2019冠状病毒病相关面部毛霉菌病的各种治疗方式及其手术治疗的必要性:一项系统综述
J Maxillofac Oral Surg. 2023 Mar 13:1-22. doi: 10.1007/s12663-023-01878-8.
6
Mortality and its determinants after an outbreak of post COVID-19 associated rhino-orbito-cerebral mucormycosis in Central India.印度中部爆发 COVID-19 相关的 rhino-orbito-cerebral mucormycosis 后死亡率及其决定因素。
Int Ophthalmol. 2023 Jul;43(7):2363-2370. doi: 10.1007/s10792-023-02634-0. Epub 2023 Jan 16.
7
Post-Covid Cerebral Mucormycosis, Varied Presentations and Surgical Strategies of a Newer Epidemic: An Institutional Experience.新冠后脑黏菌病:一种新出现的具有多种表现的流行疾病及其手术策略:一项机构经验。
Neurol India. 2022 May-Jun;70(3):1052-1056. doi: 10.4103/0028-3886.349604.
8
C-reactive Protein Kinetics During In-Patient Treatment of COVID-19-Associated Rhino-Orbito-Cerebral Mucormycosis: A Retrospective Cohort Study in a Tertiary Hospital in Central India.新型冠状病毒肺炎相关鼻眶脑毛霉菌病住院治疗期间C反应蛋白的动力学变化:印度中部一家三级医院的回顾性队列研究
Cureus. 2024 Apr 25;16(4):e59007. doi: 10.7759/cureus.59007. eCollection 2024 Apr.
9
COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.COVID-19 相关的鼻眶脑毛霉菌病:系统评价、荟萃分析和荟萃回归分析。
Indian J Pharmacol. 2021 Nov-Dec;53(6):499-510. doi: 10.4103/ijp.ijp_839_21.
10
The ROC Staging System for COVID-related Rhino-Orbital-Cerebral Mucormycosis.新型冠状病毒相关鼻眶脑毛霉菌病的ROC分期系统
Semin Ophthalmol. 2022 Apr 3;37(3):279-283. doi: 10.1080/08820538.2021.1946094. Epub 2021 Jul 14.

本文引用的文献

1
Is mucormycosis the end? A comprehensive management of orbit in COVID associated rhino-orbital-cerebral mucormycosis: preserving the salvageable.是否意味着毛霉菌病的终结?COVID 相关的鼻-眶-脑毛霉菌病的全面管理:保留可挽救的。
Eur Arch Otorhinolaryngol. 2023 Feb;280(2):819-827. doi: 10.1007/s00405-022-07620-3. Epub 2022 Sep 2.
2
Storm of a rare opportunistic life threatening mucormycosis among post COVID-19 patients: A tale of two pathogens.新冠疫情后患者中罕见的危及生命的机会性毛霉菌病风暴:两种病原体的故事
Int J Crit Illn Inj Sci. 2022 Jan-Mar;12(1):38-46. doi: 10.4103/ijciis.ijciis_48_21. Epub 2022 Mar 24.
3
Clinical Features and Mortality of COVID-19-Associated Mucormycosis: A Systematic Review and Meta-Analysis.COVID-19 相关毛霉菌病的临床特征和死亡率:系统评价和荟萃分析。
Mycopathologia. 2022 Jun;187(2-3):271-289. doi: 10.1007/s11046-022-00627-8. Epub 2022 Mar 21.
4
Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.COVID-19 时代的 ROCM(鼻眶脑毛霉菌病)流行的手术和医学管理及其结果- 一家三级护理中心的经验。
J Mycol Med. 2022 May;32(2):101238. doi: 10.1016/j.mycmed.2021.101238. Epub 2021 Dec 25.
5
A Proposed Grading System and Experience of COVID-19 Associated Rhino Orbito Cerebral Mucormycosis from an Indian Tertiary Care Center.印度一家三级护理中心提出的COVID-19相关鼻眶脑毛霉菌病分级系统及经验
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):3505-3512. doi: 10.1007/s12070-021-02986-y. Epub 2021 Nov 15.
6
Rhino-orbito-cerebral Mucormycosis: Pictorial Review.鼻眶脑毛霉菌病:影像学综述
Insights Imaging. 2021 Nov 12;12(1):167. doi: 10.1186/s13244-021-01109-z.
7
Diabetes mellitus and Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): A wake-up call from Egypt.糖尿病与冠状病毒病(COVID-19)相关毛霉菌病(CAM):来自埃及的警钟。
Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102195. doi: 10.1016/j.dsx.2021.102195. Epub 2021 Jul 8.
8
The ROC Staging System for COVID-related Rhino-Orbital-Cerebral Mucormycosis.新型冠状病毒相关鼻眶脑毛霉菌病的ROC分期系统
Semin Ophthalmol. 2022 Apr 3;37(3):279-283. doi: 10.1080/08820538.2021.1946094. Epub 2021 Jul 14.
9
COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs.新型冠状病毒肺炎相关毛霉菌病:迫切需要重新审视免疫抑制药物的滥用问题。
Ther Adv Infect Dis. 2021 Jun 18;8:20499361211027065. doi: 10.1177/20499361211027065. eCollection 2021 Jan-Dec.
10
Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.COVID-19 相关毛霉菌病:全球及印度病例报告的系统综述。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102146. doi: 10.1016/j.dsx.2021.05.019. Epub 2021 May 21.